**Teladoc (TDOC) experienced a notable increase in its stock price, closing 5.1% higher at $5.57 on the last trading session. This rise followed a Deutsche Bank upgrade from Hold to Buy, driven by the company’s low valuation and plans for its BetterHelp segment. The estimated quarterly loss for Teladoc is projected at $0.31 per share, a significant 63.2% decline year-over-year, with expected revenues of $614.34 million, down 2.4% from the previous year.**
**Stock performance in the telehealth industry has seen shifts, with Teladoc currently holding a Zacks Rank of #3 (Hold). In comparison, Bausch + Lomb (BLCO) closed 0.6% lower at $17.12, with a consensus EPS estimate for its upcoming report having risen 43.5% to $0.07, indicating a year-over-year change of +200%.**
